| CAHR Abstracts 2002 |
CLINICAL SCIENCES / SCIENCES CLINIQUES
ORAL PRESENTATIONS / PRÉSENTATIONS ORALES
ART II: REGIMENS, UPTAKE, AND ADHERENCE
[209] INCREASED INITIAL ANTI-HIV
ACTIVITY AND DECREASED INITIAL CD4 T CELL RESPONSE WITH EFAVIRENZ (EFV) ADDED
TO RITONAVIR (RTV) AND SAQUINAVIR (SQV) TREATMENT
CL Cooper1, C Fraser2, I Seguin1, Y
Khaliq1, D Cote1, N Hawley-Foss1, AD Badley1,
G Garber1, K Gallicano1, JB Angel1, DW Cameron1,2
1Division of Infectious Diseases, The Ottawa Hospital, University
of Ottawa, Ottawa, Ontario; 2Department of Infectious Disease Epidemiology,
Imperial College School of Medicine, London, United Kingdom
[210] CLINICAL EFFICACY OF SALVAGE REGIMENS CONTAINING
BOTH AMPRENAVIR (APV) AND LOPINAVIR/RITONAVIR (LPV/r) AS COMPARED TO SALVAGE
REGIMENS CONTAINING ONLY LPV/r STRATIFIED BY NNRTI-EXPERIENCE
M Loutfy, C Thompson, M Trpeski, C Kovacs, A Rachlis, J Goodhew,
G Rubin, K Gough, S Walmsley
University of Toronto, Toronto, Ontario
[211] ANTIRETROVIRAL PROPHYLAXIS
OF MOTHER TO CHILD TRANSMISSION (MTCT): UPTAKE AND POST PREGNANCY USE IN THE
CANADIAN WOMEN'S HIV STUDY
C Hankins1,2,3, K Pourreaux1, J-O Shu1,
A Hankins-Palmer1, N Labrie1, Canadian Women’s HIV Study
Group
1Montreal Regional Public Health Department; 2Department
of Epidemiology and Biostatistics, McGill University; 3Institut national
de santé publique, Montreal, Quebec
[212] CHANGING SUSTAINABILITY OF
INITIAL ANTIRETROVIRAL THERAPY (1995-2000)
H Krentz1, MJ Gill1, HIV Economic Study
Group
1Southern Alberta HIV Clinic
[213] THE EFFECT OF PSYCHOLOGICAL
FACTORS ON HAART ADHERENCE
William J Lancee1, Doug S Saunders2, Sean B
Rourke3, Sarah L Rubenstein2
1Mount Sinai Hospital; 2University of Toronto; 3St
Michael’s Hospital, Toronto, Ontario
[214] THE IMPACT OF BASELINE CD4+ T CELL COUNT
AND ADHERENCE ON RATES OF DISEASE PROGRESSION AMONG HIV-1 INFECTED PATIENTS
INITIATING TRIPLE DRUG THERAPY
E Wood, RS Hogg, B Yip, MV O’Shaughnessy, JS Montaner